Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Johnson & Johnson ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 USA

P: 732-524-0400 F: 732-214-0332

Description:

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 329,567,424
Shares Outstanding, K 2,682,900
Annual Sales, $ 76,450 M
Annual Net Income, $ 1,300 M
Last Quarter Sales, $ 20,009 M
Last Quarter Net Income, $ 4,367 M
36-Month Beta 0.73
% of Insider Shareholders 0.22%
% of Institutional Shareholders 65.96%

Growth:

1-Year Total Return -9.75%
3-Year Total Return 23.28%
5-Year Total Return 43.07%
5-Year Revenue Growth 13.72%
5-Year Earnings Growth 43.14%
5-Year Dividend Growth 38.33%

Per-Share Information:

Most Recent Earnings 2.06 on 04/17/18
Next Earnings Date 07/17/18
Earnings Per Share ttm 7.53
EPS Growth vs. Prev Qtr 18.39%
EPS Growth vs. Prev Year 12.57%
Annual Dividend Rate, $ 3.60
Annual Dividend Yield 2.93%
Most Recent Dividend 0.900 on 05/25/18
Next Ex-Dividends Date 05/25/18
Dividend Payable Date 06/12/18
Dividend Payout Ratio 43.75
Most Recent Split 2-1 on 06/13/01

JNJ Ratios

Ratio
Price/Earnings ttm 16.31
Price/Earnings forward 15.11
Price/Earnings to Growth 1.88
Return-on-Equity (After Tax) 30.65
Return-on-Assets (Before Tax) 13.26
Net Margin % 18.32
Debt/Equity 0.51
Price/Sales 4.31
Price/Cash Flow 12.83
Price/Book 5.20
Book Value/Share 23.58
Interest Coverage 19.92

JNJ Dividends

Date Value
05/25/18 $0.9000
02/26/18 $0.8400
11/27/17 $0.8400
08/25/17 $0.8400
05/25/17 $0.8400
02/24/17 $0.8000
11/18/16 $0.8000
08/19/16 $0.8000
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar